Dangerous Drug News

Side Effect Information About Dangerous Drugs and Medical Devices

Altrumedia
  • Home
  • About
  • Dangerous Drug News
  • Drugs
    • Fluoroquinolone Antibiotics
    • Pradaxa
    • Proton Pump Inhibitors
    • Risperdal
    • Talcum Powder
    • Taxotere
    • Xarelto
    • Zofran
  • Medical Devices
    • Essure
    • IVC Filters
    • Power Morcellators
    • Transvaginal Mesh
  • Free Case Evaluation

Pradaxa

 

Pradaxa (dabigatran) is an anticlotting drug, approved by the U.S. Food and Drug Administration (FDA) in October, 2010. It was the first of the novel oral anticoagulants (NOACs) prescribed as alternatives to warfarin. Pradaxa is more convenient for patients and their doctors. It is thought to have fewer side effects and be more effective in preventing stroke than warfarin, but for the first five years that Pradaxa was on the market there was no antidote that could stop the anticlotting effects during a bleeding event.

Pradaxa Uses

Pradaxa is prescribed to reduce the risk of blood clot formation and stroke in people with a heart rhythm abnormality called nonvalvular atrial fibrillation (AFib). It is also used to treat and prevent recurrence of dangerous blood clots in the legs, called deep vein thrombosis (DVT), and in the lungs, called pulmonary embolism (PE).

Pradaxa Convenience

When Pradaxa hit the market, it was met with enthusiasm because it was the first alternative to warfarin. Warfarin use requires routine blood monitoring and carries dietary restrictions making it inconvenient and often frustrating for patients and doctors.

Pradaxa use does not carry dietary restrictions or require routine blood monitoring, although studies have found that blood monitoring reduces the risk of dangerous and deadly bleeding events when taking Pradaxa.

Pradaxa Side Effects

Common side effects of Pradaxa include:

  • Stomach pain
  • Indigestion
  • Heartburn

More serious side effects and risks of Pradaxa use include:

  • Bleeding events, which can be fatal
  • Spinal or epidural blood clots which can cause paralysis
  • Heart attack or acute coronary syndrome
  • Liver failure

Pradaxa Bleeding

Like all blood thinners, including warfarin, Pradaxa can cause major bleeding events. When someone taking an anticlotting drug suffers trauma, even a minor injury can become serious or fatal due to excessive bleeding.

When Pradaxa hit the market, there was no antidote or reversal agent, so emergency room doctors were helpless to stop the bleeding and hundreds of patients died from Pradaxa bleeding. In 2015, an antidote called Praxbind (idarucizumab) was approved through the FDA’s accelerated approval program.

In addition to uncontrolled bleeding from trauma, Pradaxa can cause spontaneous bleeding including:

  • Internal bleeding
  • Gastrointestinal bleeding
  • Hemorrhagic stroke

Pradaxa Heart Attack Risk

In 2012, researchers from Cleveland Clinic published results of a study which found that Pradaxa users were 33% more likely to have a heart attack or acute coronary syndrome than people taking warfarin or a placebo. The study findings were published in the Archives of Internal Medicine.

Contact us today for a free case evaluation.

Share this:

  • Facebook
  • LinkedIn
  • Twitter

RSS FDA Med Watch

  • Church & Dwight Co., Inc. Issues Voluntary Nationwide Recall of Zicam® Cold Remedy Nasal Swabs, Zicam® Nasal AllClear Swabs, and Orajel™ Baby Teething Swabs Due to Microbial Contamination
  • Infusion Pump Correction: Baxter Updates Instructions for Use for Novum IQ Large Volume Pump due to Potential for Underinfusion
  • Infusion Pump Recall: Infusion Pump Thermal Damage Issue from Smiths Medical
  • Anesthesia Breathing Circuit Kit Correction: Draeger, Inc. Updates Use Instructions for VentStar Flex and Anesthesia Circuit Kits Due to Cracks in Hose That May Cause Inadequate Ventilation
  • Infusion Pump Recall: False Alarm Issue with Infusion Pump from Smiths Medical
  • Infusion Pump Recall: Infusion Pump Intermittent Connection Issue from Smiths Medical
  • Flexible Tracheostomy Tube Recall: Medtronic Removes Shiley Adult Flexible Tracheostomy Tube with TaperGuard Cuff Reusable Inner Cannula Due to Risk for Disconnection of the Flange from the Device Cannula

Recent Headlines

Diabetic Man Testing Blood Levels

Type 2 Diabetes Drugs Pose Numerous Health Risks

The hits just keep coming for Johnson & Johnson, and now its … [Read More...]

PPIs Side Effects

PPI Heartburn and Ulcer Medications May Cause Stomach Cancer

Proton pump inhibitors (PPIs) are used to treat heartburn, … [Read More...]

Johnson & Johnson Loses Second Major Talcum Powder Case

In its second trial loss in less than 3 months, Johnson & … [Read More...]

Find an Attorney

RSS US Recall News

  • Belviq Withdrawn Due to Cancer Risk
  • Common Heartburn Medication may lead to bladder, stomach, and other cancers. Zantac Lawsuits begin.
  • J&J Settles Talc Mesothelioma Settlement

RSS Lawsuits and Settlements

  • Possible Lawsuit: Suboxone Tooth Decay Legal News and Lawsuit Information
  • Possible Lawsuit: Ozempic and Mounjaro Weight Loss Lawsuit News and Legal Information
  • Possible Lawsuit: CPAP Lung Cancer Lawsuit News and Legal Information

RSS Mass Tort News

RSS Health Industry

  • Masimo Fights Ex-CEO's Bid To Ax Suit Over $450M Demand
  • Patent Office Leader Rejects IPRs Based On 12-Year Wait
  • Tobacco Cos. Sue Philip Morris Over Bid To Void Wash. Deal

ABOUT US

DRUG INFO

DEVICES

CASE REVIEW

NEWS

Copyright © 2025 DangerousDrugNews.com · Site Map - Website Development by Altrumedia · Log in